Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Rad51C overexpression 293T lysate (whole cell) (ab94121)

Rad51C overexpression 293T lysate (whole cell) (ab94121)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Anti-Melanoma gp100 antibody [NKI/beteb] (ab63297)
Product image
Anti-UBC4 antibody [EPR11031(B)] - BSA and Azide free (ab249183)
Product image
Anti-Lipin 2/LPIN2 antibody (ab63928)
Product image
Recombinant rhesus monkey IL-8 protein (Active) (ab243129)

Overview

  • Product name

    Rad51C overexpression 293T lysate (whole cell)
  • General notes

    ab94121 is a 293T cell transfected lysate in which Human Rad51C has been transiently over-expressed using a pCMV-Rad51C plasmid. The lysate is provided in 1X Sample Buffer. Note: For more detailed how the transfected lysate was prepared view preparation notes

  • Tested applications

    Suitable for: WBmore details

Properties

  • Mycoplasma free

    Yes
  • Form

    Liquid
  • Storage instructions

    Shipped on dry ice. Upon delivery aliquot and store at -20ºC. Avoid freeze / thaw cycles.
  • Storage buffer

    Constituents: 0.01% Bromophenol blue, 2.3% Beta mercaptoethanol, 2% Sodium lauryl sulfate, 0.788% Tris HCl, 10% Glycerol (glycerin, glycerine)
  • Concentration information loading...
  • Research areas

    • Epigenetics and Nuclear Signaling
    • DNA / RNA
    • DNA Damage & Repair
    • Homologous Recomb.
  • Background

    Function: Essential for the homologous recombination (HR) pathway of DNA repair. Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. The RAD51B-RAD51C dimer exhibits single-stranded DNA-dependent ATPase activity. The BCDX2 complex binds single-stranded DNA, single-stranded gaps in duplex DNA and specifically to nicks in duplex DNA. Participates in branch migration and Holliday junction resolution and thus is important for processing HR intermediates late in the DNA repair process. Also has an early function in DNA repair in facilitating phosphorylation of the checkpoint kinase CHK2 and thereby transduction of the damage signal, leading to cell cycle arrest and HR activation. Protects RAD51 from ubiquitin-mediated degradation that is enhanced following DNA damage. Plays a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51 and XRCC3. Contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Involved in maintaining centrosome number in mitosis. Tissue specificity: Expressed in a variety of tissues, with highest expression in testis, heart muscle, spleen and prostate. Disease: Defects in RAD51C are the cause of Fanconi anemia complementation group O (FANCO) [MIM:613390]. It is a disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. Defects in RAD51C are the cause of breast-ovarian cancer familial type 3 (BROVCA3) [MIM:613399]. It is a condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Similarity: Belongs to the RecA family. RAD51 subfamily.

Images

  • SDS-PAGE - Rad51C overexpression 293T lysate (whole cell) (ab94121)
    SDS-PAGE - Rad51C overexpression 293T lysate (whole cell) (ab94121)
    ab94121 at 15μg/lane on an SDS-PAGE gel
  • Western blot - Rad51C overexpression 293T lysate (whole cell) (ab94121)
    Western blot - Rad51C overexpression 293T lysate (whole cell) (ab94121)
    All lanes : Anti-Rad51C antibody (ab55728) at 1/500 dilution

    Lane 1 : Rad51C overexpression 293T lysate (whole cell) (ab94121)
    Lane 2 : 293T non-transfected lysate

    Lysates/proteins at 25 µg per lane.

    Secondary
    All lanes : Goat Anti-mouse IgG (H and L) HRP conjugated at 1/2500 dilution

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-MEK3 + MKK6 antibody [MKK3S189MKK6S207-D3] (ab278716)

  •  
  • Product image

    Anti-BST2/Tetherin antibody [EPR23597-202] - BSA and Azide free (ab272175)

  •  
  • Product image

    Rabbit F(ab')2 Anti-Rat IgG H&L (Alexa Fluor® 488) (ab169346)

  •  
  • Product image

    HRP Anti-GST3 / GST pi antibody [EPR8263] (ab202930)

  •  
  • Product image

    Anti-PI 3 Kinase p85 alpha antibody [EP380Y] - BSA and Azide free (ab182617)

  •  
  • Goat F(ab')2 Anti-Human IgG - (Fab')2 (FITC), pre-adsorbed (ab98604)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.